Insider filing · ARQT
Sue-jean Lin
Director
profile →
Arcutis Biotherapeutics, Inc.
ARQT · Healthcare · 65 filings in 24 months
ticker →
Sue-jean Lin sold $778K of Arcutis Biotherapeutics (ARQT)
Executed Nov 24 2025, disclosed Nov 25 2025, 1 day later.
Value, as filed
$778K
25,272 sh × $30.78
Executed
Nov 24 2025
the trade date, as filed
Disclosed
Nov 25 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SLSue-jean Lin (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $778K of ARQT (25,272 sh × $30.78, as filed), executed Nov 24 2025.
The name
ARQTHealthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sue-jean Lin in ARQT
ARQTSALE
Arcutis Biotherapeutics, Inc.
$121K4,946 sh × $24.38
Exec Jun 15
Filed Jun 17 · 5:30 PM ET